Rob Brown is a member of the Board of Directors of Ceramedix, Inc. His distinguished business experience in the pharmaceutical industry globally affords Ceramedix crucial insights and dimensions in guiding the formation and execution of our business strategy.
Throughout his thirty plus year career at Eli Lilly & Company, his roles in executive leadership included Chief Marketing Officer and Senior Vice President of Marketing. In these positions, he spearheaded marketing efforts across Lilly’s pharmaceutical business areas, including diabetes, oncology, emerging markets, and biomedicines. He served a pivotal role in launching blockbuster brands, including Taltz®, Cialis®, and Cymbalta®. Earlier in his career he served as President and General Manager of Eli Lilly’s affiliate in China, Lilly Suzhou JV, where he managed the affiliate’s expansion from a headcount of 45 to more than 500 employees and markedly improved the company’s industry sales rankings in just three years.
In addition to his industry experience, Mr. Brown has been elected to the Board of Trustees at Franklin College, where he contributes his extensive business expertise. Mr. Brown earned a bachelor’s degree in economics from DePauw University and an MBA degree from Indiana University.